Theranostics 2018; 8(14):3870-3871. doi:10.7150/thno.27810

Editorial

Oxygenating the way for enhanced chemophototherapy

Wen Jiang1, Ian Michael Delahunty1, Jin Xie1,2 ✉

1. Department of Chemistry, University of Georgia, Athens, GA 30602, USA
2. Bio-Imaging Research Center, University of Georgia, Athens, GA 30602, USA

Abstract

Hypoxia is behind tumor resistance in both chemotherapy and photodynamic therapy. This editorial highlights a study by Cai et al. [12] that a hemoglobin and human serum albumin hybrid protein nanoparticle can simultaneously deliver O2, chemotherapeutics, and photosensitizers to tumors for enhanced chemophototherapy.

Keywords: hypoxia, photodynamic therapy, chemotherapy, nanoparticles

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Jiang W, Delahunty IM, Xie J. Oxygenating the way for enhanced chemophototherapy. Theranostics 2018; 8(14):3870-3871. doi:10.7150/thno.27810. Available from http://www.thno.org/v08p3870.htm